REGN•benzinga•
Guggenheim Maintains Buy on Regeneron Pharmaceuticals, Lowers Price Target to $810
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 1, 2025 by benzinga